Key result
Deep sedation and low-dose epinephrine prompt hemodynamic stabilization and LVEF recovery from ~25% to normal.
Why the study?
COVID-19 patients with cardiac injury have an increased risk of mortality, yet the mechanisms of cardiac injury and specific conditions affecting the heart during COVID-19 remain to be determined.
Case Report (n=1)
No
Takotsubo syndrome can occur as a late complication in critically ill COVID-19 patients following physical and emotional stress such as a spontaneous breathing trial, and prompt bedside echocardiography enables rapid diagnosis and targeted management.
Answers are grounded in this paper and cite their sources.
Suggests targeted sedation-epinephrine for COVID-related Takotsubo; hypothesis-generating and requires prospective confirmation before practice change.
Coronavirus disease 2019 (COVID-19) patients with cardiac injury have an increased risk of mortality. It remains to be determined the mechanism of cardiac injury and the identification of specific conditions that affect the heart during COVID-19. We present the case of a 76-year-old woman with COVID-19 pneumonia that developed a takotsubo syndrome (TTS). Although the patient presented normal left ventricular ejection fraction and normal levels of troponin on admission, after 16 days in intensive care unit due to respiratory distress, she suddenly developed cardiogenic shock. Shock occurred few hours after a spontaneous breathing trial through her tracheostomy. Bed-side echocardiographic revealed apical ballooning promptly supporting the diagnosis of TTS. She was successfully treated with deep sedation and low dosage of epinephrine. The relevance of this case is that TTS can occur in the late phase of COVID-19. Awareness of late TTS and bed-side echocardiographic evaluation can lead to prompt identification and treatment.
No takes yet. Share an insight, caveat, or question.
Bottiroli et al. (2020) conducted a case report in COVID-19 pneumonia complicated by Takotsubo syndrome and cardiogenic shock (n=1). Deep sedation (propofol and remifentanil), low-dose epinephrine, and controlled mechanical ventilation was evaluated on Left ventricular ejection fraction (LVEF) recovery. Deep sedation and low-dose epinephrine led to hemodynamic stabilization and recovery of left ventricular ejection fraction from 25% on day 16 to 38% on day 23 and normal values by day 62.
Synapse has enriched 10 related papers. Consider them for comparative context: